blue cross blue shield of illinois glp 1 coverage Find my BlueCross BlueShield Member ID – Tava Client Help Center BCBSIL Member Programs | Blue

For the Prescribing Clinician Based on my medical history, am I a candidate for compounded semaglutide, compounded tirzepatide, or an FDA-approved option, and why

Although over 13 million beneficiaries had obesity or overweight in 2023, not all are eligible for the program that group is an estimated 3.8 million

is expanding its partnership with health care marketplace Sesame to offer prescription weight-loss drugs including Ozempic and Wegovy

It enhances exercise capacity by increasing maximum oxygen consumption and power output

Obstet Gynecol 2025;146:e98, e104

This approach helps more patients stay on the treatment, experience the full health benefits of these medications, and make real progress in reducing obesity and overweight rates in the United States."